CCATES

Lisdexamphetamine dimesilate for Attention Deficit Disorder with Hyperactivity

NT 03/2016
Authors: Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva, Wallace Breno Barbosa, Renata Cristina R. Macedo do Nascimento, Rosângela Maria Gomes e Augusto Afonso Guerra Júnior.

 

Abstract

To assess the judicial request for lisdexamphetamine dimesylate for the treatment of Attention Deficit Hyperactivity Disorder. The product is indicated for the condition proposed, although it is part of a program

 

Download Here

Adicionar Comentário